Cargando…
Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial
This randomized clinical trial (Registration: NCT03085134) assessed if an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) and reduced protein content (2.20 g/100 kcal) supports normal growth in infants with cow’s milk protein allergy (CMPA). Secondary out...
Autores principales: | Vandenplas, Yvan, Żołnowska, Marta, Berni Canani, Roberto, Ludman, Siân, Tengelyi, Zsuzsanna, Moreno-Álvarez, Ana, Goh, Anne E. N., Gosoniu, Maria Laura, Kirwan, Bridget-Anne, Tadi, Monika, Heine, Ralf G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839689/ https://www.ncbi.nlm.nih.gov/pubmed/35276889 http://dx.doi.org/10.3390/nu14030530 |
Ejemplares similares
-
Tolerance and growth in children with cow’s milk allergy fed a thickened extensively hydrolyzed casein-based formula
por: Dupont, Christophe, et al.
Publicado: (2016) -
Treatment of Cow's Milk Protein Allergy
por: Vandenplas, Yvan, et al.
Publicado: (2014) -
An Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides Modifies the Fecal Microbiome and Metabolome in Infants with Cow’s Milk Protein Allergy
por: Boulangé, Claire L., et al.
Publicado: (2023) -
Safety and tolerance of a new extensively hydrolyzed rice protein-based formula in the management of infants with cow’s milk protein allergy
por: Vandenplas, Yvan, et al.
Publicado: (2014) -
Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy
por: Canani, Roberto Berni, et al.
Publicado: (2013)